Category Patents/Designs/Trade Secrets

UPOV Marks 50 Years; Breeders Seek More Enforcement, Civil Society Wants In

This week the International Union for the Protection of New Varieties of Plants (UPOV) is celebrating its 50th anniversary. The Union is often criticised by civil society as being opaque, but plant breeders seem reasonably content with the latest version of the convention. However, some breeders that do not rely on seeds to reproduce their plants are seeking a clarification in the convention to prevent illegal use of their protected varieties.

WIPO To Launch New Drug R&D Database For Neglected Disease Licences

The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva.

EU High Court Bans Patents On Human Embryo Stem Cells For Commerce

The European Union high court today outlawed the patenting of human embryo stem cells for scientific research or commercial purposes. The decision has forced European courts to examine the “ethical boundaries of patenting,” said Greenpeace, which challenged a German patent in the case. While there are alternate methods for obtaining stem cells, the ruling will nevertheless affect some research, one patent lawyer said.

WIPO Members Embark On Busy Year Of IP Policymaking

World Intellectual Property Organization members this month approved a range of reports from WIPO negotiating committees and took note of changes within the UN agency. Now with the annual WIPO General Assemblies over, work has begun on a hefty policymaking work programme this autumn. Here’s a rundown of what’s coming.

Recommendations For Navigating IP Terrain Emerge From UNITAID Forum

The third consultative forum of drug-purchasing mechanism UNITAID held in Geneva on 4-5 October resulted in a set of recommendations related to intellectual property rights and medicines access. The forum provided the opportunity for a wide array of global health actors, industry and country representatives to review the organisation’s progress in the last five years and to provide input on its future activities.

Trade And Access To Medicines: Things The WTO Should Consider

Some pending thorny issues linked with trade and access to medicines in developing countries did not come up at the September Public Forum of the World Trade Organization. As unsolved matters closely joining together trade and equitable access to medicines, they might serve as things the WTO should consider to help keep itself relevant and interesting, writes Daniele Dionisio.

US Senator Questions Constitutionality Of ACTA

The Obama administration's recent signing of the Anti-Counterfeiting Trade Agreement may face a US constitutional challenge as a member of the US Senate today called into question the administration's power to negotiate and enter into such a trade agreement without Congress's approval.

Comings And Goings In The World Of IP

Resignations, retirements, appointments, and promotions are shaking up the status quo in the intellectual property world, opening the door of possibility for change in strategy and decision-making across industries and sectors.